This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, H. Articles by Soff, G. A. Search for Related Content PubMed PubMed Citation Articles by Wang, H. Articles by Soff, G. A.

Differential Binding of Plasminogen, Plasmin, and Angiostatin4.5 to Cell Surface ß-Actin: Implications for Cancer-Mediated Angiogenesis

¹ Division of Hematology/Oncology and ² Division of Pulmonary and Critical Care Medicine, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois and ³ Division of Hematology/Oncology, State University of New York Downstate Medical Center, Brooklyn, New York

Requests for reprints: Gerald A. Soff, Division of Hematology/Oncology, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 20, Suite 850, Brooklyn, NY 11203. Phone: 718-270-2785; E-mail: gsoff{at}downstate.edu.

Angiostatin4.5 (AS4.5) is the product of plasmin autoproteolysis and consists of kringles 1 to 4 and 85% of kringle 5. In culture, cancer cell surface globular ß-actin mediates plasmin autoproteolysis to AS4.5. We now show that plasminogen binds to prostate cancer cells and that the binding colocalizes with surface ß-actin, but AS4.5 does not bind to the cell surface. Plasminogen and plasmin bind to immobilized ß-actin similarly, with a K_d of 140 nmol/L. The binding is inhibited by -aminocaproic acid (ACA), indicating the requirement for a lysine-kringle domain interaction. Using a series of peptides derived from ß-actin in competitive binding studies, we show that the domain necessary for plasminogen binding is within amino acids 55 to 69 (GDEAQSKRGILTLKY). Substitution of Lys⁶¹ or Lys⁶⁸ with arginine results in the loss of the ability of the peptide to block plasminogen binding, indicating that Lys⁶¹ and Lys⁶⁸ are essential for plasminogen binding. Other actin peptides, including peptides with lysine, did not inhibit the plasminogen-actin interaction. AS4.5 did not bind actin at concentrations up to 40 µmol/L. Plasminogen, plasmin, and AS4.5 all contain kringles 1 to 4; however, kringle 5 is truncated in AS4.5. Isolated kringle 5 binds to actin, suggesting intact kringle 5 is necessary for plasminogen and plasmin to bind to cell surface ß-actin, and the truncated kringle 5 in AS4.5 results in its release from ß-actin. These data may explain the mechanism by which AS4.5 is formed locally on cancer cell surfaces and yet acts on distant sites. (Cancer Res 2006; 66(14): 7211-5)

This article has been cited by other articles:

				S. R. Perri, B. Annabi, and J. Galipeau Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton FASEB J, December 1, 2007; 21(14): 3928 - 3936. [Abstract] [Full Text] [PDF]

				L. A. Miles, N. M. Andronicos, N. Baik, and R. J. Parmer Cell-Surface Actin Binds Plasminogen and Modulates Neurotransmitter Release from Catecholaminergic Cells J. Neurosci., December 13, 2006; 26(50): 13017 - 13024. [Abstract] [Full Text] [PDF]